Group with highest consumption had higher cognitive construct score compared with those who consume less than one cup\/day<\/p>\n<\/h3>\n
By Elana Gotkine HealthDay Reporter<\/b>
\n<\/b><\/p>\n
THURSDAY, Dec. 26, 2024 (HealthDay News) — For elderly patients with atrial fibrillation, regular coffee consumption is associated with higher cognitive performance, according to a study published online Dec. 14 in the Journal of the American Heart Association<\/em>.<\/p>\n Massimo Barbagallo, M.D., from the University Hospital Zurich, and colleagues examined whether regular coffee consumption reduces cognitive decline in elderly adults with atrial fibrillation. A structured nutrition questionnaire was used to assess daily coffee consumption, and cognitive function was assessed using a detailed neurocognitive test battery, which combined several neurocognitive tests and provided an overall cognitive performance indicator.<\/p>\n The researchers found that the cognitive construct scores were \u22120.24 and \u22120.10 for those who consumed less than one cup\/day (reference group) and the highest consumption group (more than five cups\/day), respectively. The Montreal Cognitive Assessment score was 24.58 in the reference group and 25.25 in the group with the highest intake. A decline in inflammatory markers was seen with higher coffee consumption (nonsignificant for high-sensitivity C-reactive protein and significant for interleukin-6).<\/p>\n “Further studies are required to confirm an optimal exposure of three to five cups daily in this elderly population with AF [atrial fibrillation]. Coffee consumption in elderly patients with AF should not be discouraged,” the authors write.<\/p>\n